Avalyn Pharma Inc. (AVLN)
Market Closed
10 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
34. 56
+0.64
+1.8868%
$
1.53B Market Cap
- P/E Ratio
- Div Yield
130,354 Volume
- Eps
$ 33.92
Previous Close 
Want to track AVLN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Avalyn Pharma Inc. (AVLN) Statistics
Valuation metrics
Market Cap 1.53B
Enterprise value 1.45B
Trailing P/E (ttm) -16.63
Forward P/E -
PEG ratio -0.17
Price/Sales (ttm) -
Price/Book (mrq) -5.94
Enterprise Value/Revenue -
Enterprise Value/EBITDA -15.92
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 119.11K
Average volume (90 days) 254.68K
Price summary
52-Week low 24.15
52-Week high 35.2
Beta -
50-Day moving average 28.82
200-Day moving average 28.35
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.57%
Return on equity 0.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.04
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.31
Total debt (mrq) -
Total Debt/Equity (mrq) -0.01
Current ratio (mrq) 10.19%
Book value per share (mrq) -5.71
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
